Conference abstract
Conference abstract
Designing multivalent immunogens for vaccine optimization
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Databases now contain thousands of sequences for emerging pathogens. High definition structures have been determined for many of their proteins and even whole viruses. The current challenge is to incorporate this information into the design of 21st century vaccines, which can provide better protection against rapidly evolving pathogens. Conventional vaccines begin by modifying a single strain or combining several wild type strains. The starting point is often a historical isolate, which may have been passaged multiple times in different labs. We have developed methods to extract the information in large multiple sequence alignments to design reference sequences for viral families, and immunogens to protect against many different viruses. First, a PCP-consensus sequence that is most similar in its physical chemical properties to all the sequences in an alignment is chosen. This sequence can then be modified by altering the regions of maximum variability, and known epitopes, to obtain a stable protein that can generate protective antibodies against many different related pathogens. The PCP consensus sequence for a group of proteins (e.g., for each Dengue serotype) provides a rational reference that can be used to select the naturally occurring strain that is closest to the mean for the family. This talk will show how the method can be used to produce a tetravalent antigen against all four Dengue strains and to define the common properties of enterovirus VPgs and allergenic proteins.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of influenza B globular head vaccines
Article · 25 Jul 2024
Cross-Protection and Immune Response of Multivalent Vaccines Against Respiratory Viruses
Conference abstract · 27 Jul 2015
Development and assessment of multivalent recombinant vaccines for bovine respiration disease
Review article · 2013
Directional Activation of Intestinal Dendritic Cells by an Oral Targeted Multivalent Vaccine
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advancing Immune-Based Disease Management through Therapeutic Vaccines
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Catherine H Schein”
